Beximco Pharmaceuticals Limited (AIM: BXP)

Beximco Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	216	473	607	675	267	315
Market Cap Growth	-24.24%	-22.18%	-10.02%	152.96%	-15.36%	-8.52%
Enterprise Value	277	574	741	745	369	410
Last Close Price	0.21	0.34	0.64	0.77	0.28	0.30
PE Ratio	-	4.48	6.36	7.81	3.79	4.74
PS Ratio	0.31	1.66	1.99	2.68	1.10	1.48
PB Ratio	1.03	1.37	1.55	2.12	0.86	1.13
P/FCF Ratio	8.19	17.75	28.75	22.58	8.51	-23.25
P/OCF Ratio	6.20	10.72	13.23	13.13	5.06	11.44
EV/Sales Ratio	1.00	2.02	2.43	2.96	1.52	1.93
EV/EBITDA Ratio	4.53	9.18	10.20	11.70	5.98	7.57
EV/EBIT Ratio	5.57	11.48	12.78	13.75	7.22	9.04
EV/FCF Ratio	6.09	21.57	35.06	24.92	11.76	-30.20
Debt / Equity Ratio	0.15	0.22	0.28	0.20	0.32	0.45
Debt / EBITDA Ratio	0.78	1.21	1.50	1.02	1.62	2.32
Debt / FCF Ratio	1.17	2.89	5.16	2.18	3.18	-9.26
Asset Turnover	0.62	0.58	0.59	0.58	0.52	0.49
Inventory Turnover	1.77	1.77	1.91	2.03	1.91	1.79
Quick Ratio	0.45	0.37	0.35	0.39	0.35	0.34
Current Ratio	1.80	1.57	1.45	1.47	1.15	1.04
Return on Equity (ROE)	10.99%	9.81%	12.19%	14.73%	11.31%	10.63%
Return on Assets (ROA)	6.97%	6.38%	6.95%	7.75%	6.76%	6.55%
Return on Capital (ROIC)	8.37%	7.49%	8.06%	8.98%	7.75%	7.43%
Earnings Yield	39.96%	7.07%	7.43%	6.48%	12.52%	8.96%
FCF Yield	12.20%	5.63%	3.48%	4.43%	11.75%	-4.30%
Dividend Yield	6.45%	7.55%	4.79%	3.90%	4.56%	4.23%
Payout Ratio	29.69%	33.98%	31.68%	11.28%	17.13%	16.66%
Buyback Yield / Dilution	-	-	-	0.00%	-
Total Shareholder Return	6.45%	7.55%	4.79%	3.90%	4.56%	4.23%

Source: S&P Capital IQ. Standard template. Financial Sources.